Clinical trials of coenzyme Q₁₀ in neurological disorders

10.1111/j.1600-0404.1991.tb03962.x

10.1016/S0022-510X(98)00296-2

10.1002/ana.10479

10.1002/ana.410360613

10.1016/S0166-2236(00)01584-8

Bogentoft C., 1991, Biomedical and Clinical Aspects of Coenzyme Q10, 215

10.1016/S0022-510X(98)00006-9

10.1016/0022-510X(90)90015-F

10.1002/ana.410410514

10.1111/j.1365-2362.2005.01486.x

10.1161/01.CIR.0000146894.45533.C2

10.1212/WNL.57.3.515

10.1038/415096a

10.1038/35046114

Ferrante R., 2002, Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease, Journal of Neurosciences, 22, 1592, 10.1523/JNEUROSCI.22-05-01592.2002

10.1080/10715760290021216

10.1016/S1096-7192(02)00145-2

10.1002/mds.10024

10.1002/ana.410390317

10.1001/archneur.62.4.621

10.1001/archneur.60.8.1170-b

10.1001/archneur.62.4.621

10.1016/j.mad.2003.10.002

10.1002/ana.410410206

10.1001/archneur.62.2.317

10.1212/01.WNL.0000055089.39373.FC

10.1002/ana.1001

Lucker P. W., 1984, Biomedical and Clinical Aspects of Coenzyme, 143

10.1016/S0304-3940(03)00185-X

10.1083/jcb.200105057

10.1212/WNL.43.5.884

10.1016/0005-2760(92)90237-P

10.1212/WNL.56.7.849

10.1080/10715760290021207

10.1073/pnas.86.7.2379

10.1212/WNL.36.1.45

Okamoto T., 1989, Human serum ubiquinol‐10 levels and relationship to serum lipids, International Journal of Vitamin Nutrition Research, 59, 288

10.1074/jbc.M302297200

10.1056/NEJM199301213280305

10.1016/S0959-437X(02)00298-8

H.Reichmann A.Storch W. H.Jost P.Vieregge J.Spiegel W.Greulich J.Durner T.Mller A.Kupsch H.Henningsen W.Oertel G.FuchsandW.Kuhn Coenzym Q10‐Nanodispersion versus Plazebo zur symptomatischen Therapie von Patienten mit Morbus Parkinson. Eine multizentrische plazebokontrollierte randomisierte Doppelblindstudie 4. Deutscher Parkinson‐Kongress 2005.

10.1212/WNL.59.8.1275

10.1016/S0140-6736(00)02531-9

10.1046/j.1468-2982.2002.00335.x

10.1001/archneur.61.6.889

10.1212/01.WNL.0000151975.03598.ED

10.1002/jnr.10579

Shults C. W., 2002, Parkinson Study Group, Effects of coenzyme Q10 in early Parkinson disease‐Evidence of slowing of the functional decline, Archives of Neurology, 59, 1541, 10.1001/archneur.59.10.1541

10.1212/WNL.50.3.793

10.1016/j.expneurol.2004.05.003

10.1016/j.pharmthera.2005.02.002

10.1212/WNL.48.5.1238

The Huntington Study Group, 2001, A randomized, placebo‐controlled trial of coenzyme Q10 and remacemide in Huntington's disease, Neurology, 57, 397, 10.1212/WNL.57.3.397

Tomono Y., 1986, Pharmacokinetic study of deuterium‐labelled coenzyme Q10 in man, International Journal of Clinical Pharmacology Therapeutics and Toxicology, 24, 536

10.1002/ana.10371

10.1074/jbc.M004128200